A

Acorda Therapeutics, Inc.

Biotechnology Research · United States · 500 employees

14 Decision makers
500 Employees
$116M Revenue
1995 Founded

Organizational Chart of Acorda Therapeutics, Inc.

Roles identified within Acorda Therapeutics, Inc.'s leadership team, from public professional data, updated 25 Oct 2026.

Department

Acorda Therapeutics, Inc.'s Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Acorda Therapeutics, Inc. by function

General management

Human resources

Other functions

See all Acorda Therapeutics, Inc. contacts on Zeliq

Decision makers at Acorda Therapeutics, Inc.

14 identified 1 VP 13 Directors
See them on Zeliq →

Funding and news at Acorda Therapeutics, Inc.

Funding

Last round Debt financing
Total funding $160M (17 rounds)
Series A $1M Apr 1995
Grant $100K Jan 1996
Grant $2M Oct 1997
Grant $400K Jan 1999
Series A $34M Jan 2001
Series A $6M Mar 2001
Series B $6M May 2001
Grant $100K Aug 2001
Grant $139K Aug 2002
Grant $980K Dec 2002
Series B $55M May 2003
Grant $380K Oct 2003
Venture Round $12M Mar 2004
Grant $490K Jan 2005
Post-IPO Equity $32M Oct 2006
Post-IPO Equity $10M Nov 2006

Team Structure headcount by department

Sales
15
Other
8
Finance
7
Operations
7
Administrative
6
General Management
6
Legal
6
Medical
6

How to prospect Acorda Therapeutics, Inc.'s departments

Sales

The company's largest department, with 15 people. Talk numbers (conversion, cycle length, pipeline coverage) and you will get their attention quickly.

Other

The company's second-largest department (8 people). Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

Finance

This department counts 7 people. Timing matters here: approach them around budget planning cycles, when arbitrations are actually open.

Operations

7 people work in this department. Process efficiency and cost control are the angles that resonate with these decision makers.

Administrative

A team of 6 people. Administrative teams keep the whole organisation running: scheduling, coordination and document flows are daily pains a concrete efficiency pitch can address.

General Management

This department counts 6 people. General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Try the Zeliq email finder demo →

FAQ Acorda Therapeutics, Inc.

Who runs Acorda Therapeutics, Inc.?

The highest-ranking leadership role identified at Acorda Therapeutics, Inc. is “Sr. Vice President - HR”, based on public data updated 25 Oct 2026.

How many decision makers does Acorda Therapeutics, Inc. have?

14 decision makers identified.

How do I contact a decision maker at Acorda Therapeutics, Inc.?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Acorda Therapeutics, Inc.

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. is a company active in the Biotechnology Research space, based in United States. Founded in 1995, the company employs approximately 500 people. Acorda Therapeutics, Inc. belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Acorda Therapeutics, Inc. is a B2B company, primarily serving business clients and professional organisations. The company has secured 17 rounds of funding totalling $160M. Annual revenue is estimated at around $116M. This profile compiles key information about Acorda Therapeutics, Inc., including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Acorda Therapeutics, Inc. is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Acorda Therapeutics, Inc. primarily serves business clients and professional organisations. The company is categorised as “Public company”.